임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
55건 표시
- 2상모집 중· Cognitive DysfunctionA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
리드: 일라이 릴리
- 2상모집 중· Irritable Bowel SyndromeA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
리드: 일라이 릴리
- 2상모집 중· Colitis, UlcerativeA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
리드: 일라이 릴리
- 2상모집 중· Irritable Bowel SyndromeA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
리드: 일라이 릴리
- 2상모집 중· Alopecia AreataA Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
리드: 일라이 릴리
- 2상모집 중· Acute PainA Study of LY4515100 in Participants With Pain Following Third Molar Removal
리드: 일라이 릴리
- 2상모집 중· Ulcerative Colitis (UC)LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
리드: 일라이 릴리
- 2상모집 중· Diabetic Peripheral Neuropathic PainA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
리드: 일라이 릴리
- 2상모집 중· Opioid Use DisorderA Study of Brenipatide in Participants With Opioid Use Disorder
리드: 일라이 릴리
- 2상모집 중· Severe HypertriglyceridemiaA Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
리드: 일라이 릴리
- 2상모집 중· Bipolar DisorderA Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
리드: 일라이 릴리
- 2상모집 중· Grade 1 Follicular LymphomaPirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
협력: 일라이 릴리
- 2상모집 중· Waldenstrom MacroglobulinemiaA Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
협력: 애브비, 일라이 릴리
- 2상모집 중· Ulcerative ColitisLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
리드: 일라이 릴리
- 2상모집 중· Mantle Cell Lymphoma (MCL)Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma
협력: 일라이 릴리
- 2상모집 중· Obesity and OverweightEfficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
협력: 일라이 릴리
- 2상모집 중· Chronic Lymphocytic LeukemiaClonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
협력: 일라이 릴리
- 2상모집 중· Marginal Zone LymphomaPirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
협력: 일라이 릴리
- 2상모집 중· Chronic Lymphocytic LeukemiaA Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 일라이 릴리
- 2상모집 중· Ulcerative ColitisA Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
리드: 일라이 릴리
- 2상모집 중· Mantle Cell LymphomaPhase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
협력: 일라이 릴리
- 2상모집 중· Differentiated Thyroid CancerSelpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
협력: 일라이 릴리
- 2상모집 중· Inflammatory Bowel DiseasesA Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
리드: 일라이 릴리
- 2상모집 중· Mantle Cell LymphomaGlofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
협력: 일라이 릴리, 로슈
- 2상모집 중· Chronic Lymphocytic LeukemiaFixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
협력: 일라이 릴리
- 2상모집 중· Triple Negative Breast NeoplasmsBicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
협력: 일라이 릴리
- 2상모집 중· Chronic Lymphocytic LeukemiaPhase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
협력: 일라이 릴리, 로슈
- 2상모집 중· Low Grade Serous Ovarian CarcinomaAbemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
협력: 일라이 릴리
- 2상모집 중· Breast CancerSingle Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
협력: 일라이 릴리
- 2상모집 중· ER-Positive Breast CancerFulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
협력: 일라이 릴리
- 2상모집 중· Recurrent Endometrial CarcinomaAbemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
협력: 일라이 릴리
- 2상모집 중· Osteoarthritis, KneeA Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
리드: 일라이 릴리
- 2상모집 중· Endometrial CancerRESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
협력: 일라이 릴리
- 2상모집 중· GlioblastomaINdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
협력: 일라이 릴리
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
- 2상모집 중· Lymphoma, Non-HodgkinTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
협력: 아스트라제네카, BMS, 일라이 릴리, 노바티스, 화이자, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.